Ultragenyx Pharmaceutical Inc.
SEC Filing List
RARE CIK: 0001515673
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Horn Howard | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/02/2026 | |
| 8-K | Current report filing | Ultragenyx Pharmaceutical Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/02/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 04/01/2026 | ||
| 8-K | Current report filing | Ultragenyx Pharmaceutical Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/30/2026 | |
| ARS | Annual report to security holders | Ultragenyx Pharmaceutical Inc. | LABRADOR CO /fa | 03/27/2026 | |
| SCHEDULE 13G/A | 03/27/2026 | ||||
| SCHEDULE 13G/A | 03/27/2026 | ||||
| DEF 14A | Definitive proxy statements | Ultragenyx Pharmaceutical Inc. | LABRADOR CO /fa | 03/27/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Ultragenyx Pharmaceutical Inc. | LABRADOR CO /fa | 03/27/2026 | |
| 8-K | Current report filing | Ultragenyx Pharmaceutical Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/12/2026 | |
| No record found. | |||||
| Load More | |||||
